Search research articles
Contact Us
Filters
Showing results (191-200 of 211) with videos related to
Page
of 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1996
Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer
J Crawford, M O'Rourke, J H Schiller, et al.
Leukemia & Lymphoma
|
July 28, 2016
Survival Experience of 195 Patients with Hairy Cell Leukemia Treated in a Multi-Institutional Study with Interferon-Alfa 2B
H M Golomb, A Fefer, D W Golde, et al.
Neuro-Oncology
|
October 16, 2025
Phase I/II and Window-of-Opportunity Study of Pamiparib and Metronomic Temozolomide for Recurrent IDH Mutant Gliomas
David Schiff, Xiaobu Ye, Jing Li, et al.
Molecular Cancer Research : MCR
|
March 17, 2018
D-2-Hydroxyglutarate Is Necessary and Sufficient for Isocitrate Dehydrogenase 1 Mutant-Induced <i>MIR148A</i> Promoter Methylation
Tie Li, Christopher D Cox, Byram H Ozer, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
December 6, 2014
TDS exposure project: application of the analytic hierarchy process for the prioritization of substances to be analyzed in a total diet study
A Papadopoulos, I Sioen, F Cubadda, et al.
American Journal of Clinical Oncology
|
October 20, 2000
Carcinoma of the kidney, testis, and rare urologic malignancies
Z Petrovich, L V Baert, L W Brady, et al.
Neuro-Oncology Practice
|
June 9, 2025
Implications of sociodemographic and clinical factors on symptom burden: Age-specific survivorship care in the primary central nervous system tumor population
Kimberly R Robins, Tricia Kunst, Jennifer Reyes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2000
2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel
H Ozer, J O Armitage, C L Bennett, et al.
Blood
|
November 15, 1993
Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583
H Ozer, S L George, C A Schiffer, et al.
Frontiers in Oncology
|
March 20, 2026
Case Report: Molecular diagnostics and clinical courses of two adult spinal pilocytic astrocytoma long-term survivors with GTF2I::BRAF fusion
Lorenzo Argao, Pinar E Zerk, Hsiang-Chih Lu, et al.
Page
of 22
Search research articles
Search
Showing results (191-200 of 211) with videos related to
Sort By:
Page
of 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1996
Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer
J Crawford, M O'Rourke, J H Schiller, et al.
Leukemia & Lymphoma
|
July 28, 2016
Survival Experience of 195 Patients with Hairy Cell Leukemia Treated in a Multi-Institutional Study with Interferon-Alfa 2B
H M Golomb, A Fefer, D W Golde, et al.
Neuro-Oncology
|
October 16, 2025
Phase I/II and Window-of-Opportunity Study of Pamiparib and Metronomic Temozolomide for Recurrent IDH Mutant Gliomas
David Schiff, Xiaobu Ye, Jing Li, et al.
Molecular Cancer Research : MCR
|
March 17, 2018
D-2-Hydroxyglutarate Is Necessary and Sufficient for Isocitrate Dehydrogenase 1 Mutant-Induced <i>MIR148A</i> Promoter Methylation
Tie Li, Christopher D Cox, Byram H Ozer, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
December 6, 2014
TDS exposure project: application of the analytic hierarchy process for the prioritization of substances to be analyzed in a total diet study
A Papadopoulos, I Sioen, F Cubadda, et al.
American Journal of Clinical Oncology
|
October 20, 2000
Carcinoma of the kidney, testis, and rare urologic malignancies
Z Petrovich, L V Baert, L W Brady, et al.
Neuro-Oncology Practice
|
June 9, 2025
Implications of sociodemographic and clinical factors on symptom burden: Age-specific survivorship care in the primary central nervous system tumor population
Kimberly R Robins, Tricia Kunst, Jennifer Reyes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2000
2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel
H Ozer, J O Armitage, C L Bennett, et al.
Blood
|
November 15, 1993
Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583
H Ozer, S L George, C A Schiffer, et al.
Frontiers in Oncology
|
March 20, 2026
Case Report: Molecular diagnostics and clinical courses of two adult spinal pilocytic astrocytoma long-term survivors with GTF2I::BRAF fusion
Lorenzo Argao, Pinar E Zerk, Hsiang-Chih Lu, et al.
Page
of 22